C 33 H 46 ClNO 5 S, orthorhombic, P2
Experimental details
The squeezefunction of the programm PLATON [7] was used.
Discussion
The title compound was synthesized to be used as an antibiotic candidate to againsts omeG ram-positive bacteria.T he starting materials was pleuromutilin which was first isolated in acrystalline form from cultures of two species of basidiomycetes, Pleurotus mutilus and P. passeckerianus in 1951 [1] .The molecular modifications of pleuromutilin were focused essentially on the C-14 glycolic acid chain and three drugs were developed: tiamulin, valnemulin, and retapamulin [2] .T his class of compounds display high activities against drug-resistant Gram-positive bacteria and mycoplasmas in vitro and in vivo [3] , pharmacodynamic properties [4] and no target-specific cross-resistance to other antibiotics [5] . The crystal structure of the title compound is built up of molecules containing a5 -6-8 tricyclic carbon skeleton and abenzene ring, in which all bond lengths are in normalranges. The synthesized side chain of pleuromutilin exhibits the following torsion angles: -121.55°, 142.57°and -28.83°f or C22-S1-C23-C24, C23-C24-N1-C25 and N1-C25-C26-C31, respectively. Thep henyl ring is not coplanar with the N1=C25 fragment (dihedral angle: 25.36°). The hydrogen of the amide form an intramolecular hydrogen bond to the O4 atom of neighboring carbonyl group Table1.Data collection andhandling. _____________ *C orrespondence author (e-mail: shangrf1974@163.com) 
